Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Azauracil
RN: 461-89-2
UNII: I14TWN70LR
InChIKey: SSPYSWLZOPCOLO-UHFFFAOYSA-N

Classification Codes

  • Antimetabolites
  • Drug / Therapeutic Agent
  • Mutation Data
  • Noxae
  • Tumor Data

Molecular Formula

  • C3-H3-N3-O2

Molecular Weight

  • 113.0757
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Azauracil

Synonyms

  • 1,2,4-Triazine-3,5(2H,4H)-dione
  • 4(6)-Azauracil
  • 6-Azauracil
  • AI3-26412
  • as-Triazine-3,5(2H,4H)-dione
  • as-Triazine-3,5-diol
  • Azauracil
  • AZU
  • CCRIS 2710
  • EINECS 207-318-0
  • IPO 3834
  • NSC 3425
  • UNII-I14TWN70LR
  • USAF CB-30

Systematic Names

  • 1,2,4-Triazine-3,5(2H,4H)-dione
  • 1,2,4-Triazine-3,5-diol
  • as-Triazine-3,5(2H,4H)-dione (8CI)
  • IPO 3834

Registry Numbers

CAS Registry Number

  • 461-89-2

FDA UNII

  • I14TWN70LR

Other Registry Numbers

  • 19241-95-3
  • 31952-63-3

System Generated Number

  • 0000461892

Structure Descriptors

InChI

1S/C3H3N3O2/c7-2-1-4-6-3(8)5-2/h1H,(H2,5,6,7,8)

InChIKey

SSPYSWLZOPCOLO-UHFFFAOYSA-N

Smiles

[nH]1c(=O)[nH]c(=O)cn1

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 200mg/kg (200mg/kg)   National Technical Information Service. Vol. AD277-689,
mouse LD50 subcutaneous 2076mg/kg (2076mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Biochemical Pharmacology. Vol. 15, Pg. 408, 1966.
quail LD50 oral > 100mg/kg (100mg/kg)   Ecotoxicology and Environmental Safety. Vol. 6, Pg. 149, 1982.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 274.5 deg C   EXP
log P (octanol-water) -0.59 (none)   EXP
Water Solubility 1.66E+04 mg/L 25 EST
Vapor Pressure 1.74E-07 mm Hg 25 EST
Henry's Law Constant 1.91E-09 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 3.46E-12 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.